Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 4:45 pm Sale |
2025-03-14 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Tushar Bhikhubhai | 48,578,209 15.700% |
-5,000,000 (-9.33%) |
Filing History |
| 2025-02-10 08:59 am Sale |
2024-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
UBS Group AG | 0 0.000% |
-21,491,881 (Position Closed) |
Filing History |
| 2025-01-23 5:49 pm Sale |
2024-11-13 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Dipan | 23,828,992 7.700% |
-3,076,081 (-11.43%) |
Filing History |
| 2024-11-14 4:11 pm Sale |
2024-09-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
Mahesh Akram | 26,856,413 8.800% |
-3,528,356 (-11.61%) |
Filing History |
| 2024-10-31 6:51 pm Unchanged |
2024-10-29 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Chirag K. | 21,835,007 7.100% |
0 (Unchanged) |
Filing History |
| 2024-10-30 11:04 am Purchase |
2024-09-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
UBS Group AG | 21,491,881 6.900% |
21,491,881 (New Position) |
Filing History |
| 2024-05-13 4:15 pm Unchanged |
2024-05-09 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Tushar Bhikhubhai | 53,578,209 17.400% |
0 (Unchanged) |
Filing History |
| 2024-04-24 06:03 am Sale |
2024-03-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
Fosun International Ltd | 9,200,603 3.000% |
-9,207,053 (-50.02%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
The Vanguard Group | 13,642,387 4.450% |
594,319 (+4.55%) |
Filing History |
| 2024-01-05 4:09 pm Purchase |
2024-01-01 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
Mahesh Akram | 30,384,769 9.900% |
30,384,769 (New Position) |
Filing History |
| 2024-01-03 4:30 pm Sale |
2024-01-01 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Gautam | 2,025,454 0.070% |
-31,859,952 (-94.02%) |
Filing History |
| 2023-12-12 06:04 am Unchanged |
2023-11-07 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
Fosun International Ltd | 18,407,656 6.000% |
0 (Unchanged) |
Filing History |
| 2023-12-01 4:15 pm Purchase |
2021-12-01 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Gautam | 33,885,406 11.100% |
3,073,298 (+9.97%) |
Filing History |
| 2023-11-08 5:07 pm Unchanged |
2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Chirag K. | 21,835,007 7.100% |
0 (Unchanged) |
Filing History |
| 2023-11-08 5:05 pm Unchanged |
2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Dipan | 26,905,073 8.800% |
0 (Unchanged) |
Filing History |
| 2023-11-08 5:03 pm Purchase |
2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Gautam | 30,812,108 10.000% |
17,497,336 (+131.41%) |
Filing History |
| 2023-11-08 4:59 pm Unchanged |
2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Chintu | 25,318,839 8.300% |
0 (Unchanged) |
Filing History |
| 2023-11-08 4:55 pm Unchanged |
2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Tushar Bhikhubhai | 53,578,209 17.500% |
0 (Unchanged) |
Filing History |
| 2023-10-17 7:32 pm Unchanged |
2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Dipan | 26,905,073 14.900% |
0 (Unchanged) |
Filing History |
| 2023-10-17 7:31 pm Purchase |
2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX |
Patel Chirag K. | 21,835,007 14.160% |
534,503 (+2.51%) |
Filing History |